Cervical Spacer

Cervical Spacer


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
allograft, medical device, medical supplies, xenograft
Category
Health & Medical , Medical Devices

Cellumed

Membership
VIP
Country / Year Established
South Korea South Korea / 1997
Business type
Manufacturer
Verified Certificate

10

DUNS

Product name Cervical Spacer Certification -
Category Health & Medical
Medical Devices
Ingredients -
Keyword allograft , medical device , medical supplies , xenograft Unit Size -
Brand name - Unit Weigh -
origin Stock -
Supply type - HS code -

Product Information

Cervical Spacer

│Description│

  1. Made of 100% human bone which removes the risk of allergic reaction or side-effects caused by artificial material.
  2. Anatomical/biocompatible design for effective bone fusion.
  3. Maintain the balance of force between upper and lower spine.
  4. Assured safety with Clearant Process® which guarantees sterilization and effectiveness for bone fusion.
  5. Reduced pain compared to Titanium cage.
  6. Ready with many sizes for wide range of patients
  7. Easy-to-use instrument

 

Company Overview

01. Korea's Largest Human Tissue Bank

Since the establishment of Cellumed Human Tissue Bank in 1997, Cellumed has become the biggest tissue bank in the Republic of Korea. Cellumed also passed KFDA annual inspections as well as FDA site inspection for cGMP srandard.
Cellumed in especially well-known for Clean Room and Bio-Clearant technology which guarantees safe and effective tissue processing. The review of FDA inspectors showed that Cellumed's water system of Clean Room is' a world-class system' 

02. Powered by consistent focus on R&D

As our society is aging along with the increase in various leisure activities, demand for ideal medical devices and orthopedic medical equipment is noticeably growing. Facing this increase in demand, Cellumed expanded into the global market by exporting EOS pedicle screw and continuing to develop B-P Kness artificial knee joint system followed by the acquisition of ENDOTEC and their advanced technology.

03. Powered by consistent focus on R&D

Cellumed has continuously made huge investment in R&D sector of the company to stimulate innovational technological development as well as to motivate researchers to develop perfect treatment for musculoskeletal diseases.
Cellumed has discovered and developed Bone Morphogenetic Protein (BMP) as an innovative way of enhancing bone regeneration through years of dedication in R&D. So far, one of the BMP2 related products has become commercialized.
Also, Rafugen BMP2 passed nonclinical trial and is currently in the process of clinical trial to be authorized and licensed for market entry. Cellumed's advanced technology became possible through out commitment in R&D and will surely become a growth engine for future business.

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

Cellumed

Country / Year Established
South Korea South Korea / 1997
Membership
VIP
Business type
Manufacturer

10

DUNS

President
You In Soo
Address
Chung-Dam-dong, Hakdong-Ro, 401, Geumha Building, 9th Floor, Gangnam-gu, Seoul, Korea
Product Category
Medical Devices
Year Established
1997
No. of Total Employees
51-100
Company introduction

Cellumed Co., Ltd. has been steadily growing up and have become a frontier in the health care industry in 1997. We have been putting strenuous endeavor for the development of “better, safe, effective” medical device in order to make sound contribution to human health. Cellumed was one of the first bone banks established in Korea, and have been supplying human/bovine bone parts for various indications to our customers both domestic and overseas. L-F Fixed/Mobile Knee (TKR) made of titanium is being sold in the Korean market and now currently under the process of acquiring CE certificate. Our continuous investment on R&D has led us to address the FDA 510(k) registration of Rafugen DBM gel along with Bio BMP2 registered in Korea and South East Asian countries. We are looking for our very pertinent distributor whom Cellumed will share synergies with.

Main Markets

China China

Colombia Colombia

Dominican Rep. Dominican Rep.

India India

South Korea South Korea

U.S.A U.S.A

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more